Skip to content
TrustList
Nxt2b logo
Venture capital firm

Nxt2b

Privately owned Swedish venture capital company investing in healthcare, medical device and specialty pharmaceutical firms

  • external
  • Business
  • Management
  • Pharmaceutical
  • +1 more
Nxt2b cover

About Nxt2b

Nxt2b is a fully privately owned venture capital company. Because it needs no outside capital, it says it can decide quickly on investment opportunities.

It was started in 2011 by the Swedish entrepreneur Bengt Ågerup, who now acts as senior adviser. His earlier roles were at Pharmacia and Biomatrix, and he founded Q-Med, which was sold in 2011.

Services

  • Growth equity investment: focused on healthcare, medical devices and specialty pharmaceutical companies.
  • Early-phase commitments: long-term backing for projects of high scientific quality with reasonable business prospects.
  • Technology and consumer investment: selected stakes in companies with unusual ideas.
  • Active ownership: Support for portfolio management teams as they build their companies.

Who it serves

Ambitious entrepreneurs in healthcare and life sciences, plus some technology and consumer founders.

Key facts

  • Founded: 2011
  • Portfolio: More than 30 companies invested in
  • Ownership: Fully private

Profile written by TrustList from the business's own published information, Oct 2026.

Categories & features

  • external
  • Business
  • Management
  • Pharmaceutical
  • Medical

What the business tells TrustList

Founded
2011 (15 years) evidence sent

Ask TrustList to introduce you to Nxt2b

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

Reviews

Write the first review of Nxt2b

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Nxt2b.

Nxt2b alternatives

Similar listings buyers compare against this one.

Oslo-based private investment company backing early and later-stage life science businesses

A seed and early-stage venture firm backing digital companies in essential industries such as healthcare and energy

Life sciences venture firm supporting biotech and health companies through private financing and public markets

Venture capital firm investing in global insurtech and fintech companies from Tel Aviv

New York investment manager providing long-term growth capital to healthcare and therapeutics companies